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Abstract
Intracellular cyclic GMP concentration is known to change in response to a wide variety of agents, including hormones,
neurotransmitters or light. In vertebrate photoreceptors, different membrane-bound guanylate cyclase isoforms are responsi-
ble for cGMP synthesis and thus directly involved in termination of light signalling via the phototransduction cascade and
recovery of the dark state. We have characterized a 4.7 kb long cDNA for the canine retinal guanylate cyclase isoform E
 .cGC-E predicting a polypeptide of 1109 amino acids. The genomic structure and the complete sequence of the canine
GC-E gene, which consists of 20 exons and spans about 14.5 kb, has also been determined. Northern blot analysis showed
that GC-E was expressed in the canine retina as a 4.7 and 6.1 kb large transcript. RT-PCR analysis also detected low
 .expression in cerebrum occipital lobe . We performed a sequence analysis of the cGC-E gene in animals of a Swedish
Briard and Briard–Beagle dog kinship in which an inherited retinal dystrophy is segregating. Several intragenic DNA
polymorphisms were identified and used for segregation analysis which excluded cGC-E as a candidate gene for this type of
canine retinal dystrophy. q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
In vertebrate photoreceptors, 5X-cyclic guanosine
 .monophosphate cGMP plays a major role as intra-
cellular second messenger in phototransduction. The
level of cGMP in photoreceptor cells is controlled by
the hydrolyzing enzyme, cGMP-specific phosphodi-
esterase, and the synthesizing enzyme, guanylate cy-
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clase. As resynthesis of cGMP is crucial for the
opening of cGMP-gated ion channels and recovery of
the dark state, guanylate cyclase is a key enzyme in
the quenching step of phototransduction.
 .Retinal guanylate cyclase retGC is a member of
the guanylate cyclase superfamily. Two major forms
of guanylate cyclases can be distinguished; the solu-
 . w xble and the particulate membrane form 1 . All
membrane-bound guanylate cyclases, including
retGC, are composed of a large single polypeptide
with a ligand binding N-terminal domain, a trans-
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membrane domain, an internal protein kinase homol-
ogy region, and a C-terminal cGMP catalytic domain.
Recent studies have demonstrated the existence of
several different guanylate cyclase isoforms in mam-
malian retina. GC-F and ROS-GC2 are expressed
w xonly in the retina 2,3 , while GC-E is present both in
the retina and pineal gland. Natriuretic peptide recep-
w x w xtors GC-A 4,5 and GC-B 6 are expressed in many
w x w xtissues. For the isoforms GC-E 2,7,8 , GC-F 2,9
w xand ROS-GC2 3 , ligands are unknown.
The progressive retinal dystrophy found in Swedish
Briard and Briard–Beagle dogs is an autosomal re-
w xcessive disorder with complete penetrance 10–14 .
Night blindness is a constant finding in affected
animals. Except for the first two animals identified
initially, day vision was also severely affected or the
animals became totally blind. The biochemical defect
is unknown. Analysis by direct current electroretinog-
raphy showed signs suggestive of severely delayed
w xphototransduction 11 . Mutations in human genes
encoding various proteins involved in the phototrans-
duction cascade have been identified during the past
years as the primary genetic cause of different types
of retinal degeneration. By analogy, one could hy-
pothesize that canine retinal dystrophies are caused
by mutations in the canine equivalents of the genes
known to cause retinal disease in other animal species
and human. To date, only a single, disease-related
mutation has been identified in a canine retina-specific
w xgene; Suber et al. 15 reported a nonsense mutation
in the gene encoding the b-subunit of rod photore-
ceptor cGMP-specific phosphodiesterase in the
early-onset rodrcone dysplasia of Irish setters. The
importance of GC-E for normal vision has recently
been demonstrated by two independent lines of evi-
dence. First, Perrault et al. have demonstrated that
mutations in the human GC-E homologue retGC,
.encoded by GUC2D result in the earliest and most
severe form of inherited retinopathy, Leber congeni-
tal amaurosis, in a portion of families of Arab origin
w x16 . Second, a null mutation in the photoreceptor
GC-E gene has recently been identified as the pri-
mary genetic defect of the retinal degeneration in rd
w xchicken 17 . In order to analyse its possible involve-
ment in the retinal dysplasia observed in a Swedish
Briard and Briard–Beagle kindred presenting with
some phenotypic similarities to Leber amaurosis in
human, we have characterized the cDNA and gene
encoding the canine homologue of bovine ROS-GC
and human retGC, i.e., the dog retinal guanylate
cyclase, cGC-E.
2. Materials and methods
2.1. Animals
The dogs examined in the present study were bred
at the Swedish University of Agricultural Sciences,
Faculty of Veterinary Medicine, Department of
Medicine and Surgery in Uppsala.
2.2. Purification of retinal mRNA and synthesis of
cDNA
 .Poly A q RNA was prepared from frozen
 .y708C tissues of a cross-bred and an affected
w  .  .Briard dog using Dynabeads Oligo dT Dynal25
according to the manufacturer’s recommendations.
Reverse transcription reaction was carried out using 1
 .ml of mRNA ;1 mg in 50 ml volume at 378C for
 .1 h with SuperScripte Gibco, Life Technologies
and oligoT or random hexamers as synthesis22
primers. The cDNA pool was used subsequently for
further PCR reactions. Double-stranded cDNA ds
. cDNA for RACE rapid amplification of cDNA
. w xends -PCR 18,19 was generated from retinal mRNA
of normal and affected animals using the Marathone
 . cDNA amplification Kit Clontech . Adaptors Clon-
.tech for the RACE-PCR were ligated to the ends of
the ds cDNA and the construct was used for RACE-
PCR.
2.3. Amplification of the canine GC-E cDNA with
RACE-PCR
For the RACE-PCR we used the Marathone cDNA
Amplification Kit following the manufacturer’s in-
structions. The 3X-end of the canine retinal GC-E
cDNA was amplified from the canine retinal cDNA
X  Xpool using 3 -RACE with primer GC3 5 TTCAC-
X .CACCATCTCAGCCAT3 and adaptor-specific
AP1. A second, nested PCR was carried out using
1:100 diluted first-round PCR products as template
 Xwith nested primer GC3N 5 CAACAAACCCATCC-
X.CCAAAC3 , deduced from the consensus sequence
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of the conserved catalytic domain of bovine, human,
and mouse analogues, and with the adaptor-specific
primer AP2. The amplicon, containing the 3X-end of
the cGC-E cDNA from exon 18 to the start of the
polyA signal, was sequenced and used to design
primers for further experiments. Another primer pair
 .sequence available on request , based on the homol-
ogy among mammalian retinal guanylate cyclases in
exon 2, was designed and used with canine-specific
primers in exon 19 to amplify the middle region of
the cDNA. Primers for 5X-RACE were adaptor-
specific, AP1, and canine GC-E exon 2-specific,
 XGCW1 5 CACAGGTCCTGGGGCGCGGTGAT-
X.TAG3 . Amplified PCR products were used for sub-
sequent nested PCR with adaptor-specific nested
primer AP2 and gene-specific primer GCW2
 X X .5 GCGCGGAACAGGGCGTACAGAGCATC3 .
PCR reactions were carried out in a final volume of
25 ml with 1 ml of template cDNA or diluted PCR
.product and 0.5 U Taq polymerase. We used a
touch-down PCR procedure to increase both fidelity
w xand yield of PCR 20 . After an initial denaturation
 .step 3 min at 958C amplification was performed for
X 3 -RACE as three cycles of denaturation 10 s at
.  . 958C , annealing 10 s at 608C , and elongation 30 s
.at 728C , followed by three cycles of annealing at
588C, 30 cycles of annealing at 568C the other
.parameters were unaltered , and a final elongation
 . Xstep 5 min at 728C . Nested 3 -RACE-PCR was
performed at annealing temperatures 62–60–588C
 . Xother parameters were the same . For 5 -RACE
first-round PCR was performed with the addition of
5% of DMSO in the PCR mixture, at annealing
temperatures 67–65–638C, and nested PCR with an-
nealing temperatures 66–64–628C. PCR products
were purified by QIAquick PCR Purification Kit
 .Qiagen and both strands from an unaffected animal
 .were sequenced using primers 5 pmol specific to
the amplicon and dRhodamine Terminator Ready
 .Reaction Sequencing Kit Applied Biosystems on an
automatic flurometric DNA sequencer Applied
.Biosystems DNA Sequencing System, Model 373A .
2.4. Characterization of the cGC-E gene
Genomic DNA from an unaffected cross-bred dog
was isolated from peripheral blood by conventional
methods. To amplify genomic DNA, overlapping ex-
onic primers were designed based on the dog cDNA
sequence. For amplification of the long introns 7 and
8 we used the TaqPlus Precisione PCR system
 .Stratagene . Large introns were sequenced by the
primer walking method. To determine the sequence
 .of the longest intron a3 , for which direct amplifica-
tion was not successful, we used the method of rapid
 . w xamplification of genomic DNA ends RAGE 21
 .and the Universal GenomeWalkereKit Clontech .
Based on the canine cDNA data and the genomic
 . w xorganization of the human GUC2D 16 and mouse
w x22 GC-E genes, we predicted the exon–intron
boundaries of the canine gene. Data analysis was
done with LASERGENE software for Windows 95
 . w xDNASTAR, Madison , BLAST 23 , GENSCAN
w xsoftware 24 , and RepeatMasker2 Web.
2.5. Northern blot and RT-PCR analysis
 .mRNA 5 mg from various dog tissues was sepa-
rated on 1% denaturing formaldehyde-agarose gels,
transferred to positively charged nylon membranes
 .Boehringer by capillary transfer, and hybridized
overnight at 428C with a 32P-labeled 1321-bp long
PCR-amplified cDNA fragment cDNA nucleotides
.3180–4500 of cGC-E. Blots were washed for 5 min
at 428C in 2=SSCr0.1% SDS and twice for 10 min
at 428C with 0.1=SSCr0.1% SDS. Autoradiogra-
phy was performed at y708C for 2–5 days. RT-PCR
was done using the cDNA pool prepared from vari-
ous tissues. PCR was performed using forward primer
 X X.GC391 5 CCAGCCAGCCCTTGGATAAC3 in
combination with reverse primer GC1970
 X X.5 ACACGACCTCCTGCATGATG3 to amplify a
594-bp long fragment spanning exons 7–11 nucleo-
.tides 1822–2415 . Touch-down PCR annealing tem-
peratures were 608–588–568C.
2.6. PCR-SSCP analysis of the GC-E gene
 . w xSingle-strand conformation analysis SSCP 25
and silver staining of the gels were performed as
w xdescribed elsewhere 26,27 . PCR fragment size used
for SSCP was 120–420 bp. All DNA samples with
band shifts in the SSCP electrophoresis were purified
and cycle sequenced as described before.
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3. Results
3.1. Characterization of the canine GC-E cDNA
Canine retinal GC-E cDNA was amplified using
5X- and 3X-RACE techniques and both strands of the
overlapping PCR amplicons were sequenced directly.
The full-length canine GC-E cDNA obtained is 4687
bp long and contains an open reading frame between
nt 183 and 3512 see GenBank accession number
.Y15483 . The transcription initiation site was not
determined directly. However, sequencing of 5X-
RACE-PCR products detected a 112-bp long first
exon, which is four nucleotides larger than the bovine
w x X homologue 28 . The 3 -UTR is 1174-bp long without
.the polyA tail and contains a variant polyadenylation
signal, ATTAAA, 34 bp before the polyA tract.
Amino acid alignment of various vertebrate GC-E
homologues is shown in Fig. 1.
3.2. Structure of the canine GC-E gene
The complete exon and intron sequence was deter-
mined and, for the coding part, confirmed by compar-
ison to the cDNA sequence see GenBank accession
.number Y15484 . The canine GC-E gene is com-
posed of 20 exons, the first and last one are non-cod-
ing. The exons are interrupted by 19 introns, and the
 .gene spans over 14 kb genomic DNA Fig. 2 . The
exonrintron structure is similar to the human and
bovine homologues.
A search for repetitive elements with Repeat-
Masker2 revealed a LINE element long terminal re-
peat and a retroviral long terminal repeat element in
 .intron 3 of the dog GC-E gene Fig. 2 . Three short
interspersed nucleotide elements Can SINE, Gen-
.Bank accession no. X57357 , which represent most
likely tRNA-derived retroposons specific to the
w xCanoidea superfamily 29 , are located in intron 7 and
8. In addition, there is evidence for a medium reitera-
tion element MER45B in intron 7, and for medium
reiteration elements MER5A in intron 19 and exon
20.
3.3. Expression analysis
Northern analysis of mRNA from various dog
tissues demonstrated two prominent transcripts of
about 4.7 kb and 6.2 kb, both of them only in retinal
 .  .tissue Fig. 3 . The predominant band 4.7 kb corre-
sponds to the dog cDNA size determined here.
In contrast to the results of Northern blot analysis,
which demonstrate expression of dog GC-E only in
retina among all tissues examined, low level of ex-
 .pression in dog brain occipital lobe was also de-
tected by RT-PCR. No amplification products were
observed for the other tissues studied.
3.4. Sequence ˝ariants and segregation data
SSCP analysis and subsequent direct sequencing of
the coding part and, at a limited extent, of intronic
sequences of the dog GC-E gene revealed several
polymorphic changes. In intron 13, we found a single
base pair variant, 11207TrC, while, in intron 18, a
 .GTGCTCC heptamer nucleotides 12 582–12 588
duplication was identified numbers according to the
sequence deposited in GenBank under the entry
.Y15484 . We have studied 36 unrelated Briard and
foxhounds dogs to determine the allele frequency of
the 11207TrC and GTGCTCC-duplication polymor-
phisms. The heterozygosity value for the first poly-
morphism is Hs0.491, with allele frequencies of
0.434 and 0.566 for T and C, respectively. The
heterozygosity value for the second polymorphism is
Hs0.413 with allele frequencies 0.709 for one and
0.291 for two repeats.
Furthermore we found four missense mutations in
the coding region of the canine retinal guanylate
cyclase gene. One unaffected dog is heterozygous for
the 2795GrA change in exon 14. This nucleotide
variant predicts a nonconservative amino acid change,
 w x w xFig. 1. Amino acid alignment of canine retinal GC-E with other vertebrate retinal guanylate cyclases human retGC 7 ; cow ROS-GC 8 ;
w x w x.mouse GC-E 22 , and rat GC-E 7 . Amino acid sequences were aligned for maximal homology using the Clustal algorithm of the
w  .DNASTAR software gap penalty 10 . Only differences from canine retinal GC-E sequence are indicated. Amino acid residue numbers
are given on the right. The four polymorphic amino acid substitutions detected in the canine GC-E are underlined and shown above the
wild-type sequence. The canine GC-E cDNA sequence has been deposited in the GenBank database under the accession number Y15483.
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Fig. 2. Structure of the dog GC-E gene. Exons are indicated as numbered boxes. The extracellular domain is encoded by exons 2–4, while
exon 5 corresponds to the transmembrane domain. The kinase-like and cyclase catalytic domains are encoded by exons 6–12 and 13–19,
 .  .respectively. The start ATG and stop TGA codons are indicated by vertical arrows. Horizontal arrows represent repeat elements; a,
LINE element long terminal repeat; b, retroviral long terminal repeat; c, medium reiteration element MER45B; d–f, short interspersed
 .nucleotide element Can SINE ; g–h, medium reiteration elements MER5A.
 .  .871 Met ATG to Ile ATA , in the catalytic domain.
The M871I allele seems to be rare, as we have not
found it in 36 control animals. In exon 4, we found
two nucleotide changes on the same allele, 1319CrA
and 1321ArT, which lead to two amino acid substi-
 .  .tutions, 380-Ala GCC to Asp GAC and 381-
 .  .Thr ACG to Ser TCG , at the same time. The double
nucleotide substitution creates a novel restriction site
for XmnI, which gives rise to restriction fragments of
93 and 305 bp following restriction digestion of the
398-bp large amplicon. In the Swedish Briard and
Briard–Beagle dogs, all but one of the unaffected
animals were homozygous for this latter allele Fig.
.4 . Two animals from the control group also carried
the variant allele in heterozygous form. Using two
further allelic nucleotide changes in exon 2, 264GrA
Fig. 3. Expression pattern of the canine GC-E. Left panel: Northern blot analysis of canine GC-E mRNA in different dog tissues. Lane 1:
 .retina, 2: cerebrum, 3: liver, 4: kidney, 5: cardiac muscle, and 6: skeletal muscle. Estimated molecular weight kb is shown on the left
 .and has been calculated by using RNA molecular weight markers Boehringer Mannheim visualized by ethidium bromide staining. Right
panel: RT-PCR analysis of GC-E expression in various tissues. A 594-bp long fragment spanning exons 7 to 11 was amplified and
 .separated on an 1.5% agarose gel. Lane 1: skeletal muscle, 2: cardiac muscle, 3: kidney, 4: liver, 5: cerebrum occipital lobe , 6: retina,
 .and 7: molecular weight marker w X174 RF DNArHaeIII fragments .
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Fig. 4. Detection of the sequence polymorphisms 1319CrA and
1321ArT in exon 4 of the canine GC-E gene by restriction
enzyme analysis. The PCR-amplified 398 bp fragment was di-
gested with Hinf I and separated on 2% SeaKem agarose gel.
Lane 1: homozygous pattern of 1319C and 1321A unaffected
.control ; lanes 2, 4, and 7: homozygous pattern of 1319A and
 .1321T affected animals ; lanes 3, 6: homozygous pattern of
 .1319A and 1321T unaffected animals ; lane 5: double heterozy-
 .gous sample 1319CrA and 1321ArT unaffected animal ; lane
8: molecular weight marker w X174 RF DNArHaeIII frag-
.ments .
 .and 266 CrG Fig. 5 , which should lead to the
 .  .amino acid change 28-Gly GGC to Arg AGG , we
could exclude GC-E as a causative gene of the retinal
dystrophy, as affected dogs carried different alleles in
 .homozygous form Fig. 5 . This latter amino acid
change is in the variable putative signal sequence of
guanylate cyclase and represents a common polymor-
Fig. 5. Detection of the sequence polymorphisms 264GrA and
 .266CrG in canine GC-E gene exon 2 by direct sequencing. a
 .  .Affected dog homozygous for 264G and 266C 28Gly ; b
 .Affected dog homozygous for 264A and 266G 28Arg .
phism as the same change has also been found in the
control group.
4. Discussion
In the present communication, we report the char-
acterization of the gene and cDNA encoding canine
 .retinal guanylate cyclase GC-E . The cDNA is 4687-
bp long and the longest open reading frame predicts a
1109 amino acid protein with a calculated molecular
 .weight of 119.92 kDa prior to protein modification .
Although both the rat and bovine primary GC-E
w xtranscripts are much larger, about 8.5 2 and 7.5 kb
w x28 , respectively, the size of the proteins is quite
 .similar 115–120 kDa in all three species. The pro-
tein is slightly acidic with an isoelectric point of 6.82.
 .The coding sequence is very GC rich 67% . The
percent of similarity of the canine retGC-E, at the
amino acid level, is the highest with the bovine
 .homologue 88.0% and the lowest with the mouse
 .85.7% . The most obvious differences among the
various retinal GC-E homologues are in the 5X-end of
the transcript, which contains 50 amino acids repre-
senting the putative N-terminal hydrophobic signal
w xpeptide 7 . The cyclase catalytic domains are the
most conserved regions, followed by the kinase-like
domains.
The GC-E gene structure seems to be highly con-
served among vertebrates. All functionally important
domains are encoded by a separate set of exons, a
feature which is in line with the hypothesis that most
membrane guanylate cyclase genes are derived from
w xa common ancestral gene 22 . Exon sizes range from
81 to 1158 nucleotides. Each of the splice junctions is
w xin good agreement with the GTrAG rule 30 and
also the adjacent sequences follow the consensus
 .pattern Table 1 . In introns 3, 7, 8, 19, and 20 of the
canine GC-E gene, we found different repetitive ele-
ments characteristic to all vertebrates. The SINE
elements detected share 70–93.9% identity with the
original canine specific SINE element found by Min-
w xnick et al. 31 . All together, the different repetitive
elements recognized account for about 17% of the
gene.
The expression pattern of the canine GC-E gene is
of special interest. The presence of two abundant
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Table 1
Position and nucleotide sequence of exonrintron boundaries of the canine GC-E gene. Exon sequence is shown in uppercase letters;
intron sequence is in lowercase letters
 .  .Exon Exon length bp Splice donor site Intron length bp Splice acceptor site
1 110 TCCGgtgagtggca 279 ggggttgcggAGAG
a b .  .2 803 AGAGgtaggttccc 1 94 cggtccgcagCGGT 2
 .  .3 305 GCAGgtagagggac 3 2690 cctggcgcagGTGT 1
 .  .4 352 GGAGgtgagggcaa 1 380 gcttctgcagGAGT 2
 .  .5 85 TGAGgtgagtatgg 2 234 cctctaccagGCAT 3
 .  .6 103 AAAGgtgggacagc 3 391 taccctccagGTGG 1
 .  .7 102 TGAAgtgagtttta 3 1994 tctactccagGGAG 1
 .  .8 81 CAAGgtgagggtgg 3 1172 tccctcccagCTCC 1
 .  .9 207 CAAGgtgcggggta 3 87 gccgccccagGGAA 1
 .  .10 157 GAGGgtaagattcc 1 443 cggcccccagACCA 2
 .  .11 150 GAGGgtacgcagcc 3 595 atgccttcagAAGT 1
 .  .12 149 CCAGgtcaggggct 3 484 ctccaactagTTTA 1
 .  .13 164 CTCCgtgcgtcccc 3 91 ccatctctagTTCT 1
 .  .14 193 CAAGgtgggctgtg 3 216 cttcccgcagGTGG 1
 .  .15 175 TCGGgtacctagag 1 248 gtctccgcagGCCC 2
 .  .16 99 CTGCgtgagtggag 1 117 gtcattccagCTTA 2
 .  .17 95 GAAGgtgaggctat 3 120 gttcccccagGGCA 1
 .  .18 86 CGGGgtgaggtgcc 2 128 tctcccgcagCGCC 3
19 110 GCAGgtgctgcccc 559 tctctctcagGGTA
20 1158
a,bNumbers indicate, respectively, the position of the last and first exonic nucleotide within the respective codon.
mRNA species in the retina may indicate the use of
 .alternative poly A addition sites, alternative promo-
tor usage with different transcription start sites, or
alternatively-spliced guanylate cyclase variants. While
our Northern blot data show abundant expression of
GC-E in the retina and are therefore in good agree-
w xment with those obtained by other authors 2,28 ,
RT-PCR analysis revealed also low expression in
 .cerebrum occipital lobe . Heterotopic expression of
retina-specific guanylate cyclase has been shown for
w xrat GC-E in pineal gland but not in brain 2 . Yet,
further careful studies are needed to confirm this
novel finding and exclude a possible artifact.
Among the various polymorphisms found in the
 .cGC-E gene, the substitution 380-Ala GCC to
 .Asp GAC is the most interesting as all species char-
 .acterized so far human, cow, mouse, and rat carry
invariantly alanine at this position in the extracellular
domain of guanylate cyclase. The polymorphisms
264GrA and 266 CrG found in exon 2 were helpful
to exclude this gene as causative for the retinal
degeneration found in Swedish Briard and Briard–
Beagle dogs. Due to the high degree of inbreeding,
affected animals are expected to be homozygous not
only for the disease causing mutation but also for all
other nonpathogenic sequence variations of the same
gene. Therefore, a heterozygous pattern for any se-
quence change or homozygosity in affected animals
for two different alleles of the same sequence variant
provides a genetic proof to exclude the gene in
question as the one implicated in the retinal disorder
in this strain. The involvement of six further retina-
specific genes in the eye disease of this strain of dogs
has already been excluded previously, e.g., those
encoding rhodopsin, the b-subunit of rod photorecep-
tor cGMP phosphodiesterase, peripherinrRDS, ar-
 .restin, rod outer membrane protein ROM1 , and the
a-subunit of rod cGMP-gated cation channel
w x27,32,33 . Nevertheless cCG-E and all the other
genes listed before are good candidates for the nu-
merous other canine retinal degenerations found in
different breeds.
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